‘BIG HEALTH’ and Sustainable Entrepreneurship as 2 Key Thrusts for the Group in 2023

PETALING JAYA, 2 March 2023 – Amway (Malaysia) Holdings Berhad (“AMWAY Malaysia”) is committed to further strengthening its efforts to address non-communicable diseases (NCDs) including a key focus on weight management by launching the “Gut Reset-Weight Management” educational and awareness campaign nationwide. This is in line with AMWAY Malaysia’s efforts to support Malaysia’s focus towards preventive healthcare as the growing prevalence of NCDs is placing an increased strain on the country’s health system, with an annual healthcare cost exceeding RM9.65 billion.[1]

Diabetes, high cholesterol, high blood pressure and obesity are a growing health problem for many Malaysians, as evidenced by alarming statistics. According to the National Health and Morbidity Survey (NHMS) 2019, an estimated 1.7 million Malaysians have three major risk factors for cardiovascular disease, while 3.4 million Malaysians have two major risk factors. In addition, the NHMS found that about one in five adult Malaysians live with diabetes, one in three with hypertension, two in five with high cholesterol and nearly half are either overweight or obese.[2]

AMWAY Malaysia’s Managing Director, Mr Michael Jonathan Duong said, “In response to our government’s strategy to support the fight against non-communicable diseases, AMWAY, as a leading health and wellness company, recognizes the critical role of the private sector in addressing our national health concerns. With this in mind, AMWAY Malaysia is stepping up efforts to provide healthier lifestyle products and solutions through the “Gut Reset-Weight Management” educational and awareness campaign, with the aim of encouraging Malaysians to adopt a healthy lifestyle to avoid the risks of non-communicable diseases.”

As AMWAY’s flagship brand, Nutrilite™ offers a range of nutritional and dietary supplements that help improve overall wellness. The “Gut Reset-Weight Management” campaign has a core focus on healthy gut as it is a critical precursor to healthy weight in the long term. The campaign will include a personalized weight and nutritional needs management programme that encompasses a balanced diet, supplements, exercise and a holistic lifestyle change. The programme is aimed at providing essential daily nutrients and fibre one needs for overall weight control. In addition, the programme offers an individual health screening through an exclusive partnership with Innoquest Pathology, a leading diagnostic company in Malaysia for over 30 years. The launch of the “Gut Reset-Weight Management” campaign forms an important milestone for AMWAY Malaysia this year, further strengthening Nutrilite™’s market position globally for nearly 90 years.

Tackling NCDs is one of AMWAY Malaysia’s key thrusts within its 6 Pillars of Focus for 2023, referred to as the “BIG HEALTH” initiative. And as consumers increasingly focus on health and wellness, AMWAY Malaysia will continue to offer product solutions that are infused with technology and rely on sound research to support a healthier lifestyle for Malaysians.

For 2023, AMWAY Malaysia’s second focus is to build a more sustainable entrepreneurship model to support Amway Business Owners (ABOs), which will drive the Group’s business growth. “One of the most important aspects of our business is to sustain and grow our AMWAY entrepreneurs. We strive to support our Amway Business Owners in their entrepreneurial journey towards generating sustainable income and creating value through mutually beneficial partnerships by helping them discover their full potential and achieve their goals. With over 400,000 ABOs within our network, we continuously focus on ABO-centric programmes and incentives, as we journey together towards AMWAY Malaysia’s 50^th anniversary vision to be one of the leading health and wellness companies in Malaysia by 2026,” Duong said.

AMWAY Malaysia registered a new record revenue of RM1,514.8 million in the financial year ended December 31, 2022 (FY2022), up 1.9% from RM1,485.9 million recorded in the previous financial year. The increase in sales was mainly due to strong demand for health and wellness as well as personal care products under the Lead with Nutrition initiative. Meanwhile, its net profit recorded a stellar growth of 109% to RM76.88 million compared to RM36.78 million registered in FY2021.

“AMWAY Malaysia has never been stronger, and we are certainly looking forward to building a profitable, sustainable future.” Duong concluded.

[1] The annual health-care cost of cardiovascular diseases, diabetes and cancer in Malaysia exceeds RM 9.65 billion

[2] National Health and Morbidity Survey 2019